Trial intelligence / Profile preview

Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Dry Eye Syndrome

NCT01753752Phase 2Completed

Sponsor
Gerhard Garhofer
Start
Sep 2012
Primary completion
Mar 2013
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of chitosan-N-acetylcysteine in dry eye syndrome (DED), sponsored by Gerhard Garhofer. Started Sep 2012; status: completed.

02

Drugs

chitosan-N-acetylcysteine
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on NCT01753752.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01753752.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call